361 studies found for:    nicotinamide
Show Display Options
Rank Status Study
1 Unknown  Nicotinamide Versus Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients
Conditions: Chronic Renal Failure;   Hemodialysis
Interventions: Drug: nicotinamide;   Drug: sevelamer;   Drug: cinacalcet
2 Recruiting Nicotinamide Safety Study
Conditions: Pregnancy Induced Hypertension;   Superimposed Preeclampsia;   Hypertension
Intervention: Drug: Nicotinamide
3 Active, not recruiting Niacin on Immune Activation : a Proof-of-concept Study
Condition: HIV
Intervention: Drug: Niacin
4 Completed Biosynthesis of PGD2 in Vivo
Condition: Healthy Volunteer
Interventions: Dietary Supplement: 5 days of placebo followed by 600mg niacin;   Dietary Supplement: aspirin first;   Drug: 81 mg Aspirin;   Dietary Supplement: Niaspan;   Drug: Celebrex and niacin
5 Recruiting Anticancer Activity of Nicotinamide on Lung Cancer
Condition: Non-Small-Cell Lung Carcinoma
Intervention: Drug: Nicotinamide
6 Completed Short-term Effect of Extended-release Niacin on Endothelial Function.
Condition: Hypoalphalipoproteinemia
Intervention: Drug: Niacin
7 Completed Assessment of Interaction Between Vytorin and Niaspan in Healthy Subjects (P04955AM2)
Conditions: Hypercholesterolemia;   Hyperlipidemia
Interventions: Drug: Vytorin + Niaspan;   Drug: Vytorin;   Drug: Niaspan
8 Recruiting The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE
Condition: Chronic Kidney Disease
Interventions: Drug: Nicotinamide;   Drug: Lanthanum Carbonate;   Drug: Placebo (for Nicotinamide);   Drug: Placebo (for lanthanum carbonate)
9 Completed Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis
Condition: Healthy Volunteers
Interventions: Drug: Niacin;   Other: Placebo
10 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
11 Completed Nicotinamide in the Treatment of Psoriasis
Condition: Psoriasis
Interventions: Drug: Calcipotriol plus Nicotinamide;   Drug: Calcipotriol
12 Completed Niacin, N-3 Fatty Acids and Insulin Resistance
Conditions: Metabolic Syndrome;   Hypertriglyceridemia
Interventions: Drug: omega-3 acid ethyl esters;   Drug: extended release niacin;   Drug: placebo;   Drug: combined treatment
13 Completed
Has Results
Phase I Vorinostat in Combination With Niacinamide and Etoposide for Lymphoid Malignancies
Conditions: Hodgkin's Disease;   Non-Hodgkin's Lymphoma
Interventions: Drug: Vorinostat;   Drug: Niacinamide;   Drug: Etoposide
14 Completed Comparison of TRIA-662 500 mg and Niaspan 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions
Condition: Healthy
Interventions: Drug: Niaspan;   Drug: TRIA-662
15 Completed Pharmacokinetic Analysis of Nicotinamide Riboside
Condition: Healthy Participants
Intervention: Dietary Supplement: Nicotinamide riboside
16 Active, not recruiting Olive Oil on Nampt and Its Relation With Postprandial Inflammation and Atherosclerosis in the Setting of Metabolic Syndrome.
Condition: Metabolic Syndrome
Interventions: Dietary Supplement: Niacin;   Dietary Supplement: Saturated meal;   Dietary Supplement: Monounsaturated meal;   Dietary Supplement: Polyunsaturated meal
17 Active, not recruiting Effect of Nicotinamide in Friedreich's Ataxia
Condition: Neurodegenerative Disorders
Intervention: Drug: nicotinamide
18 Completed Effect of Niacin in the Lipoprotein (a) Concentration
Condition: Hypercholesterolemia
Intervention: Drug: Niacin/Laropiprant
19 Completed Niacin/Laropiprant and Endothelial Function
Condition: Coronary Heart Disease
Interventions: Drug: Niacin/laropiprant;   Drug: Placebo
20 Completed Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
Condition: Ischemic Stroke
Interventions: Drug: Extended-Release Niacin;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years